Burchert, A., Wölfl, S., Schmidt, M., Brendel, C., Denecke, B., Cai, D., . . . Neubauer, A. (2003). Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia. Blood, 101(1), . https://doi.org/10.1182/blood-2002-02-0659
Chicago Style (17th ed.) CitationBurchert, Andreas, et al. "Interferon-α, but Not the ABL-kinase Inhibitor Imatinib (STI571), Induces Expression of Myeloblastin and a Specific T-cell Response in Chronic Myeloid Leukemia." Blood 101, no. 1 (2003). https://doi.org/10.1182/blood-2002-02-0659.
MLA (9th ed.) CitationBurchert, Andreas, et al. "Interferon-α, but Not the ABL-kinase Inhibitor Imatinib (STI571), Induces Expression of Myeloblastin and a Specific T-cell Response in Chronic Myeloid Leukemia." Blood, vol. 101, no. 1, 2003, https://doi.org/10.1182/blood-2002-02-0659.